Cardiff University life sciences spin-out Asalus Medical Instruments receives green light to begin rolling its Ultravision product across European Union hospitals.
Asalus Medical Instruments has received the CE mark for its Ultravision system, giving the Wales-based firm the green light to begin introducing its products across EU hospitals.
The company, a spin-out of Cardiff University, has developed Ultravision as a system to handle surgical smoke produced during laparoscopic surgery, commonly known as keyhole surgery.
Commercialisation firm Fusion IP, which has exclusivity rights to commercialise Cardiff’s intellectual property, holds a 44% stake in the company. It is joined by Finance Wales and the IP Group, which has just made a takeover bid for Fusion.
Ann Casey, investment executive at Finance Wales, said: “Achieving the CE Mark on its Ultravision product is a significant milestone for Asalus. It will now be the springboard for its commercialisation phase. This is a major step forward in Asalus’ development, and we wish the team well.”
